GW&K Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $67.3M | Sell |
309,419
-65,512
| -17% | -$14.5M | 0.59% | 43 |
|
|
2025
Q4 | $85.7M | Sell |
374,931
-847
| -0.2% | -$193K | 0.74% | 23 |
|
|
2025
Q3 | $87M | Sell |
375,778
-6,207
| -2% | -$1.26M | 0.77% | 23 |
|
|
2025
Q2 | $70.9M | Sell |
381,985
-14,747
| -4% | -$2.74M | 0.63% | 37 |
|
|
2025
Q1 | $83.1M | Buy |
396,732
+83,245
| +27% | +$16.2M | 0.77% | 20 |
|
|
2024
Q4 | $55.7M | Sell |
313,487
-7,294
| -2% | -$1.34M | 0.47% | 68 |
|
|
2024
Q3 | $63.3M | Sell |
320,781
-5,064
| -2% | -$945K | 0.54% | 58 |
|
|
2024
Q2 | $55.9M | Sell |
325,845
-7,013
| -2% | -$1.16M | 0.51% | 66 |
|
|
2024
Q1 | $60.6M | Sell |
332,858
-3,678
| -1% | -$634K | 0.53% | 62 |
|
|
2023
Q4 | $52.2M | Sell |
336,536
-9,204
| -3% | -$1.34M | 0.49% | 74 |
|
|
2023
Q3 | $51.5M | Sell |
345,740
-7,838
| -2% | -$1.15M | 0.52% | 70 |
|
|
2023
Q2 | $47.6M | Sell |
353,578
-43,834
| -11% | -$6.43M | 0.45% | 88 |
|
|
2023
Q1 | $63.3M | Buy |
397,412
+4,359
| +1% | +$666K | 0.61% | 44 |
|
|
2022
Q4 | $63.5M | Sell |
393,053
-2,899
| -0.7% | -$445K | 0.64% | 36 |
|
|
2022
Q3 | $53.1M | Sell |
395,952
-4,585
| -1% | -$658K | 0.59% | 53 |
|
|
2022
Q2 | $61.3M | Sell |
400,537
-19,836
| -5% | -$3.03M | 0.66% | 33 |
|
|
2022
Q1 | $68.1M | Sell |
420,373
-44,524
| -10% | -$6.47M | 0.61% | 44 |
|
|
2021
Q4 | $62.9M | Sell |
464,897
-2,772
| -0.6% | -$327K | 0.53% | 64 |
|
|
2021
Q3 | $50.4M | Buy |
467,669
+2,096
| +0.5% | +$240K | 0.45% | 80 |
|
|
2021
Q2 | $52.4M | Sell |
465,573
-789
| -0.2% | -$88.9K | 0.46% | 78 |
|
|
2021
Q1 | $50.5M | Sell |
466,362
-5,751
| -1% | -$615K | 0.46% | 74 |
|
|
2020
Q4 | $50.6M | Sell |
472,113
-3,307
| -0.7% | -$318K | 0.53% | 49 |
|
|
2020
Q3 | $41.6M | Sell |
475,420
-5,695
| -1% | -$536K | 0.55% | 55 |
|
|
2020
Q2 | $47.2M | Sell |
481,115
-6,271
| -1% | -$552K | 0.66% | 33 |
|
|
2020
Q1 | $37.1M | Sell |
487,386
-8,592
| -2% | -$732K | 0.65% | 42 |
|
|
2019
Q4 | $43.9M | Sell |
495,978
-4,381
| -0.9% | -$364K | 0.59% | 46 |
|
|
2019
Q3 | $37.9M | Buy |
500,359
+72,240
| +17% | +$4.95M | 0.53% | 55 |
|
|
2019
Q2 | $31.1M | Sell |
428,119
-8,027
| -2% | -$631K | 0.47% | 77 |
|
|
2019
Q1 | $35.1M | Sell |
436,146
-1,900
| -0.4% | -$155K | 0.57% | 53 |
|
|
2018
Q4 | $40.4M | Sell |
438,046
-13,265
| -3% | -$1.17M | 0.8% | 28 |
|
|
2018
Q3 | $42.7M | Sell |
451,311
-9,070
| -2% | -$860K | 0.69% | 35 |
|
|
2018
Q2 | $42.7M | Sell |
460,381
-14,476
| -3% | -$1.41M | 0.7% | 38 |
|
|
2018
Q1 | $44.9M | Sell |
474,857
-92,097
| -16% | -$10.1M | 0.76% | 33 |
|
|
2017
Q4 | $54.8M | Sell |
566,954
-9,213
| -2% | -$868K | 0.94% | 18 |
|
|
2017
Q3 | $51.2M | Sell |
576,167
-50,955
| -8% | -$3.88M | 0.85% | 22 |
|
|
2017
Q2 | $45.5M | Buy |
627,122
+124,717
| +25% | +$8.38M | 0.78% | 36 |
|
|
2017
Q1 | $32.7M | Buy |
502,405
+20,594
| +4% | +$1.29M | 0.62% | 66 |
|
|
2016
Q4 | $30.2M | Buy |
481,811
+27,365
| +6% | +$1.67M | 0.59% | 66 |
|
|
2016
Q3 | $28.7M | Buy |
454,446
+27,094
| +6% | +$1.75M | 0.54% | 77 |
|
|
2016
Q2 | $26.5M | Buy |
427,352
+25,529
| +6% | +$1.56M | 0.55% | 78 |
|
|
2016
Q1 | $23M | Buy |
401,823
+20,300
| +5% | +$1.13M | 0.51% | 87 |
|
|
2015
Q4 | $22.6M | Sell |
381,523
-373
| -0.1% | -$21.5K | 0.53% | 81 |
|
|
2015
Q3 | $20.8M | Buy |
381,896
+9,935
| +3% | +$647K | 0.5% | 89 |
|
|
2015
Q2 | $25M | Buy |
371,961
+90,893
| +32% | +$5.93M | 0.57% | 72 |
|
|
2015
Q1 | $16.5M | Buy |
281,068
+17,317
| +7% | +$1.05M | 0.37% | 103 |
|
|
2014
Q4 | $17.3M | Buy |
263,751
+3,469
| +1% | +$219K | 0.41% | 91 |
|
|
2014
Q3 | $15M | Buy |
260,282
+8,272
| +3% | +$459K | 0.39% | 98 |
|
|
2014
Q2 | $14.2M | Buy |
252,010
+246,610
| +4,567% | +$12.9M | 0.36% | 102 |
|
|
2014
Q1 | $278K | Sell |
5,400
-1,700
| -24% | -$85.9K | 0.01% | 213 |
|
|
2013
Q4 | $375K | Hold |
7,100
| – | – | 0.01% | 205 |
|
|
2013
Q3 | $318K | Sell |
7,100
-200
| -3% | -$8.87K | 0.01% | 204 |
|
|
2013
Q2 | $302K | Buy |
+7,300
| New | +$319K | 0.01% | 195 |
|
Other funds holding ABBV
VCM
VPM
GW&K Investment Management's ABBV Position: Q1 2026 in Review
GW&K Investment Management reduced its AbbVie (ABBV) stake by 17% in Q1 2026, selling an estimated $14.5M and leaving 309,419 shares worth $67.3M. The position accounts for 0.59% of the portfolio, ranked #43.
GW&K Investment Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $87M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- GW&K Investment Management held 309,419 shares of AbbVie worth $67.3M as of Q1 2026.
- GW&K Investment Management sold 65,512 AbbVie shares in Q1 2026, an estimated $14.5M.
- AbbVie made up 0.59% of GW&K Investment Management's portfolio in Q1 2026, its #43 holding.
- GW&K Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- GW&K Investment Management's AbbVie position peaked at $87M in Q3 2025.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on GW&K Investment Management's 13F filing for Q1 2026, filed 13 May 2026.